Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now
- PMID: 21435939
- DOI: 10.1016/j.drup.2011.02.003
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now
Abstract
Two commercial databases (Pharmaprojects and Adis Insight R&D) were queried for antibacterial agents in clinical development. Particular attention was given to antibacterial agents for systemic administration. For each agent, reviewers were requested to indicate whether its spectrum of activity covered a set of selected multidrug-resistant bacteria, and whether it had a new mechanism of action or a new target. In addition, PubMed was searched for antibacterial agents in development that appeared in review articles. Out of 90 agents that were considered to fulfil the inclusion criteria for the analysis, 66 were new active substances. Fifteen of these could be systemically administered and were assessed as acting via a new or possibly new mechanism of action or on a new or possibly new target. Out of these, 12 agents were assessed as having documented in vitro activity against antibiotic-resistant Gram-positive bacteria and only four had documented in vitro activity against antibiotic-resistant Gram-negative bacteria. Of these four, two acted on new or possibly new targets and, crucially, none acted via new mechanisms of action. There is an urgent need to address the lack of effective treatments to meet the increasing public health burden caused by multidrug-resistant bacteria, in particular against Gram-negative bacteria.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.J Antimicrob Chemother. 2009 Oct;64(4):810-4. doi: 10.1093/jac/dkp281. Epub 2009 Aug 7. J Antimicrob Chemother. 2009. PMID: 19666647
-
Tigecycline: first of a new class of antimicrobial agents.Pharmacotherapy. 2006 Aug;26(8):1099-110. doi: 10.1592/phco.26.8.1099. Pharmacotherapy. 2006. PMID: 16863487 Review.
-
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.Int J Antimicrob Agents. 2010 Jun;35(6):531-6. doi: 10.1016/j.ijantimicag.2010.02.008. Epub 2010 Mar 25. Int J Antimicrob Agents. 2010. PMID: 20346634
-
Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.Drug Resist Updat. 2011 Apr;14(2):107-17. doi: 10.1016/j.drup.2011.02.005. Epub 2011 Mar 26. Drug Resist Updat. 2011. PMID: 21440486 Review.
-
In vitro activity of ertapenem: review of recent studies.J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204. J Antimicrob Chemother. 2004. PMID: 15150179 Review.
Cited by
-
Biofilms: Formation, drug resistance and alternatives to conventional approaches.AIMS Microbiol. 2022 Jul 4;8(3):239-277. doi: 10.3934/microbiol.2022019. eCollection 2022. AIMS Microbiol. 2022. PMID: 36317001 Free PMC article. Review.
-
Use of Metagenomics and Isolation of Actinobacteria in Brazil's Atlantic Rainforest Soil for Antimicrobial Prospecting.ISRN Biotechnol. 2014 Mar 12;2014:909601. doi: 10.1155/2014/909601. eCollection 2014. ISRN Biotechnol. 2014. PMID: 25937991 Free PMC article.
-
Dimeric lipo-α/sulfono-γ-AA hybrid peptides as broad-spectrum antibiotic agents.Biomater Sci. 2021 May 4;9(9):3410-3424. doi: 10.1039/d0bm01955k. Biomater Sci. 2021. PMID: 33949388 Free PMC article.
-
Functional Site Discovery in a Sulfur Metabolism Enzyme by Using Directed Evolution.Chembiochem. 2016 Oct 4;17(19):1873-1878. doi: 10.1002/cbic.201600264. Epub 2016 Aug 12. Chembiochem. 2016. PMID: 27411165 Free PMC article.
-
The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics.Pathogens. 2022 Aug 18;11(8):931. doi: 10.3390/pathogens11080931. Pathogens. 2022. PMID: 36015050 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical